Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin

drugsJune 17, 2019

Tag: FDA , Kanjinti , trastuzumab-anns , Herceptin

PharmaSources Customer Service